Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI
Glycolytic metabolism of pathogenic T cells enables early detection of GVHD by 13C-MRI
复制标题
DOI:
10.1182/blood.2020005770
复制
发表时间:
2021-01-07
期刊:
影响因子:
20.3
通讯作者:
Buxbaum, Nataliya P.
中科院分区:
文献类型:
--
作者:
Assmann, Julian C.;Farthing, Don E.;Buxbaum, Nataliya P.
Graft-versus-host disease (GVHD) is a prominent barrier to allogeneic hematopoietic stem cell transplantation (AHSCT). Definitive diagnosis of GVHD is invasive, and biopsies of involved tissues pose a high risk of bleeding and infection. T cells are central to GVHD pathogenesis, and our previous studies in a chronic GVHD mouse model showed that alloreactive CD4(+) T cells traffic to the target organs ahead of overt symptoms. Because increased glycolysis is an early feature of T-cell activation, we hypothesized that in vivo metabolic imaging of glycolysis would allow noninvasive detection of liver GVHD as activated CD4(+) T cells traffic into the organ. Indeed, hyperpolarized C-13-pyruvate magnetic resonance imaging detected high rates of conversion of pyruvate to lactate in the liver ahead of animals becoming symptomatic, but not during subsequent overt chronic GVHD. Concomitantly, CD4(+) T effector memory cells, the predominant pathogenic CD4(+) T-cell subset, were confirmed to be highly glycolytic by transcriptomic, protein, metabolite, and ex vivo metabolic activity analyses. Preliminary data from single-cell sequencing of circulating T cells in patients undergoing AHSCT also suggested that increased glycolysis may be a feature of incipient acute GVHD. Metabolic imaging is being increasingly used in the dinic and may be useful in the post-AHSCT setting for noninvasive early detection of GVHD.